Thursday November 4, 2004
Adult Bone Marrow Stem Cells Deliver Cancer Therapy Without Side Effects
HOUSTON, November 4, 2004 (LifeSiteNews.com) - Stem cells taken from bone marrow are being used to reproduce the effects of a cancer treatment called interferon beta and avoiding toxic side effects. Researchers at the University of Texas have reported in Wednesday's issue of the Journal of the National Cancer Institute that experiments with cancerous mice have had positive results killing cancer cells, without damaging surrounding tissue.
The mice which underwent the stem cell treatment lived significantly longer than those treated with the interferon alone and than those with no treatment. Mice with human breast cancer treated with the engineered human stem cells survived for 60 days. Mice treated with interferon beta alone lived for 41 days. Mice with melanoma treated with the stem cells survived 73.5 days, compared with 30 days for untreated mice
Research team member, Dr. Michael Andreeff, said the stem cells moved like guided missiles, targeting tumor cells and producing high concentrations of therapeutic proteins within the tumor cells. Andreeff, a professor at the University of Texas M.D. Anderson Cancer Center, plans to test the treatment on humans within a year.
New York Times coverage (registration required):
http://www.nytimes.com/aponline/health/AP-Stem-Cells-Tumor.html
ph
Latest Headlines
- Cardinal Rigali: You Can't Claim to be "Reducing Abortions" but Publicly Funding them in D.C.

- General Electric to Use Embryonic Stem Cells for Testing, Phase out Lab Rats

- Ohio Supreme Court Allows Planned Parenthood to Conceal Abortion Records in Sexual Abuse Case

- LifeSiteNews Canada Day and Independence Day Message. Taking a few days off. LSN returns Monday July 6

- Heroically Pro-Life Brazilian Archbishop's Resignation Accepted Under Cloud of Vatican Newspaper Misrepresentation

- Pro-Life Groups Announce New Colorado Personhood Initiative

- Judge Puts Kibosh on DC Gay "Marriage" Referendum

- Al Franken Win Hands Supermajority to Senate Democrats

- Group Funded by Canadian Bishops' D&P Joins with Others to Denounce the "Natural Family" and "Family Rights"

- Financially Troubled Planned Parenthood of El Paso Closes Doors

- Abortion Linked to Subsequent Pre-Term Births, New Research Again Confirms

- New Orleans Homosexual Couple Ask Fed. Court to Overturn Marriage Amendment

- Slim Hope Of New Ontario Progressive Conservative Party Leader Promoting Pro-Life, Pro-Family Issues

- Pope Accepts Resignation of Bishop Caught Involved in Homosexual Encounters

- Young Children Removed from UK Schools for "Inappropriate Sexual Behaviour"

- Northern Ireland Politician Cleared of Wrongdoing after Reiterating Christian Teaching on Homosexual Acts

- UK Conservative Leader Speaks at Gay Pride Fundraiser

- More Letters to the Editor on Canadian Catholic Development and Peace Scandal (July 1)

- Letters to the Editor - Readers Respond to Development and Peace Scandal

- Watch This Dramatic New Video on Catholic Bishops Conference Funding of Pro-Abortion Groups

Most Read this Week
- Homosexual Duke U. Director Charged with Offering Adopted 5-Year-Old for Sex
- Famed Fr. Corapi Calls Canadian Bishops' Dissent from Humanae Vitae "Catastrophic"
- Pope: It is a Childish Faith to Oppose the Church Teaching on Life and Family
- LifeSiteNews Detailed Response to Canadian Bishops' Whitewash Report on Development and Peace
- Heroically Pro-Life Brazilian Archbishop's Resignation Accepted Under Cloud of Vatican Newspaper Misrepresentation
- Young Children Removed from UK Schools for "Inappropriate Sexual Behaviour"
- Is Pro-Choice the New Pro-Life?
- General Electric to Use Embryonic Stem Cells for Testing, Phase Out Lab Rats
- Swedish Parents Won't Tell if Child is Boy or Girl as Gender Experiment
- Cardinal Rigali: You Can't Claim to be "Reducing Abortions" but Publicly Funding them in D.C.
MORE NEWS:
LifeSiteNews.com Home Page
Last 10 Days
Archives
Special Reports
Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.







Back to Top